BlueSphere Bio appoints industry veteran Jonathan Peacock

PITTSBURGH: PITTSBURGH, Aug. 19, 2021 /PRNewswire/ -- BlueSphere Bio announces the appointment of Jonathan Peacock as Chairman of the Board of Directors in its pursuit to build an industry leading Board and executive team to develop their groundbreaking immune–oncology T cell receptor (TCR) T-cell discovery platform and clinical programs. As...

Click to view original post